Currently Enrolling Studies
Help us advance our research mission. Here's how you can get involved.
The goal of all clinical research, and particularly clinical trials, is to discover new approaches to conditions currently without a treatment or to developing more effective treatment options. We are always looking for volunteers willing to join us on this journey. In fact, we couldn’t do it without you. Here are our currently enrolling studies:
Adolescent schizophrenia
A six-week Phase 3 double-blind clinical study of brexpiprazole with option for open-label rollover for treatment of adolescent schizophrenia.
- Eligibility criteria: volunteers ages 13-17 with a current primary diagnosis of schizophrenia or history (diagnosis or symptoms) of the disease for at least six months before screening.
- Projected enrollment start date: Spring 2022
- Principal investigator: Sharon Cain, M.D.
Prader-Willi syndrome
Phase 2/3, randomized, double‑blind, placebo‑controlled study for the treatment of hyperphagia in Prader‑Willi syndrome
- Eligibility criteria: Children and adults up to 65 years, referrals appreciated
- Enrollment: Closed
- Principal investigator: Ann Genovese, M.D.
For more information about this study, contact Christa Wessel, MHA/ED, EMT, Clinical Research Coordinator, at 913-574-0302 and cwessel@kumc.edu.
BEST Trial (Low Back Pain)
A 9-month clinical trial of treatments for chronic low back pain.
Eligibility criteria:
- Have had low back pain for at least 3 months
- Are 18 years old or older
- Are willing to try one or two treatments for chronic low back pain
Principal Investigator: Andrea Chadwick, M.D.
Contact: Facelab@kumc.edu
Fibromyalgia
One-time online survey (approximately 15-20 mins) assessing patient’s understanding of fibromyalgia.
Eligibility criteria:
- Females and males 18 years and older
- Diagnosed with fibromyalgia
Principal Investigator: Lora Black, Ph.D., MPH
Contact: Facelab@kumc.edu